Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Mayo Clinic
Mayo Clinic
NRG Oncology
Mayo Clinic
Centre Oscar Lambret
Mayo Clinic
University Hospital, Montpellier
University of Washington
City of Hope Medical Center
GCS Ramsay Santé pour l'Enseignement et la Recherche
University of Iowa
British Columbia Cancer Agency
The Netherlands Cancer Institute